Research programme: calcitonin/glucocorticoid combination therapies - Unigene Laboratories
Alternative Names: sCT-GC combination therapyLatest Information Update: 28 Feb 2011
At a glance
- Originator University of London
- Developer Unigene Laboratories
- Class Glucocorticoids; Neuropeptides; Peptide hormones
- Mechanism of Action Calcitonin receptor agonists; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory bowel diseases; Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 28 Feb 2011 No development reported - Preclinical for Inflammatory bowel disease in USA (PO)
- 28 Feb 2011 No development reported - Preclinical for Osteoarthritis in USA (PO)
- 28 Feb 2011 No development reported - Preclinical for Rheumatoid arthritis in USA (PO)